Asia Healthcare Blog
Exploring the intersection of investment and development, in Asia



Business & Investment

February 8, 2012

Additional Information on Hong Kong’s Approach to Senior Care

09325885a71053d24d4c7249a965_grande

Earlier this year I had the opportunity to tour Hong Kong Housing Society’s senior care facility, Cheerful Court, and meet with several of their management people.  Since that time, I have been doing additional research on the senior care infrastructure in Hong Kong, which is presented below via SlideShare

In many ways, Hong Kong provides the opportunity to look at a geographic and cultural analog for the need and potential solution that will work in China.  Of note are four take aways that the HKHS approach suggests will be equally, if not more so, problematic in China:

  • The role of the Hong Kong government was not helpful – in fact in complicated operational decisions and ROI.  For those eager to see the Chinese government get involved, keep in mind the sort of strings that typically come with governmental involvement and find ways to minimize them.
  • Even in Hong Kong, a middle income solution is still needed.  The high end market has a solution (both facility based and in-home).  What remains the unsolved problem is a cost-effective middle class set of solutions.
  • Longer lifespans mean longer ROI horizons.  Sounds simple, but for the HKHS, planned versus actual turnover has extended the runway and reduced ROI expectations.
  • I think this is the single biggest issue:  even in a developed market like Hong Kong with all sorts of ancillary nursing and geriatric care that has been formalized in healthcare systems and medical training, the need for trained eldercare staff is acute.  In the short term, this begs the question for operators in China of how they can address this, but it also suggests that for a savvy entrepreneur, finding a way to establish to training program in China might be the first scalable and profitable commercial opportunity that is monetized in China’s senior care market.


About the Author

Benjamin
Ben is the Founder and Managing Director of Rubicon Strategy Group, a consulting firm specializing in helping American and European companies enter emerging markets. He is a member of the National Committee on US-China Relations and holds an advisory board seat at Indiana University’s Research Center on Chinese Politics and Business. He is a columnist for the Asia Times on US-China trade and economic policy matters, with a particular focus on how relations between the two countries are being impacted post the 2008 financial crisis. As a founder of the consulting firm Teleos, he was an early advocate for Chinese companies moving away from cost-only business models towards ones that emphasized brand building, innovation and product development. He founded Teleos Healthcare which licensed, capitalized and commercialized the IP for an OTC medical appliance used to help stop nosebleeds. This company successfully partnered with a major US pharmaceutical company on the product launch for the hemophilia and VWD bleeding disorder community. In addition, Ben has successfully managed projects in China across a number of industries, ranging from consumer goods to more complex engineered products. He holds his MBA from Duke University in Durham, North Carolina.




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>